Literature DB >> 6451625

Fructose 2,6-bisphosphate. A new activator of phosphofructokinase.

S J Pilkis, M R El-Maghrabi, J Pilkis, T H Claus, D A Cumming.   

Abstract

A new activator of rat liver phosphofructokinase was partially purified from rat hepatocyte extracts by DEAE-Sephadex chromatography. The activator, which eluted in the sugar diphosphate region, was sensitive to acid treatment but resistant to heating in alkali. Mild acid hydrolysis resulted in the appearance of a sugar monophosphate which was identified as fructose 6-phosphate by gas chromatography/mass spectroscopy. These observations suggest that the activator is fructose 2,6-bisphosphate. This compound was synthesized by first reacting fructose 1,6-bisphosphate with dicyclohexylcarbodiimide and then treating the cyclic intermediate with alkali. The structure of the synthetic compound was definitively identified as fructose 2,6-bisphosphate by 13C NMR spectroscopy. Fructose 2,6-bisphosphate had properties identical with those of the activator purified from hepatocyte extracts. It activated both the rat liver and rabbit skeletal muscle enzyme in the 0.1 microM range and was several orders of magnitude more effective than fructose 1,6-bisphosphate. Fructose 2,6-bisphosphate was not a substrate for aldolase or fructose 1,6-bisphosphatase. It is likely that this new activator is an important physiologic factor of phosphofructokinase in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Upregulation of heart PFK-2/FBPase-2 isozyme in skeletal muscle after persistent contraction.

Authors:  Jordi Rovira; Jose Maria Irimia; Mario Guerrero; Joan Aureli Cadefau; Roser Cussó
Journal:  Pflugers Arch       Date:  2012-01-13       Impact factor: 3.657

2.  Acute troglitazone action in isolated perfused rat liver.

Authors:  K Preininger; H Stingl; R Englisch; C Fürnsinn; J Graf; W Waldhäusl; M Roden
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase.

Authors:  Tatiana El-Bacha; Maíra M T Menezes; Melissa C Azevedo e Silva; Mauro Sola-Penna; Andrea T Da Poian
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

Review 4.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.

Authors:  L Hue; M H Rider
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

Review 5.  Glycolysis revisited.

Authors:  E Van Schaftingen
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  Central cavity of fructose-1,6-bisphosphatase and the evolution of AMP/fructose 2,6-bisphosphate synergism in eukaryotic organisms.

Authors:  Yang Gao; Lu Shen; Richard B Honzatko
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

7.  Fructose-2,6-P2, chemistry and biological function.

Authors:  K Uyeda; E Furuya; C S Richards; M Yokoyama
Journal:  Mol Cell Biochem       Date:  1982-10-18       Impact factor: 3.396

8.  A protein inhibitor of phosphofructokinase from the mucosa of rat small intestine. A mechanism for the regulation of glycolysis that is independent of glucose.

Authors:  G L Kellett; J P Robertson
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

9.  The effect of glucose on the activity of phosphofructokinase in the mucosa of rat small intestine.

Authors:  A Jamal; G L Kellett; J P Robertson
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

10.  Regulation of 6-phosphofructo-2-kinase activity by cyclic AMP-dependent phosphorylation.

Authors:  M R el-Maghrabi; T H Claus; J Pilkis; S J Pilkis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.